Moody's Raised Outlook for Gerresheimer

- Ba2 Rating Confirmed

DUSSELDORF, Germany, April 23 /CNW/ - The rating agency Moody's changed the outlook for the rating of Gerresheimer from stable to positive and affirmed the Ba2 rating.

Moody's gave as a reason for the positive change the company's good operating performance. At the same time Moody's referred to the strength and stability of the group's business model.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma & healthcare industry. Our wide product spectrum ranges from pharmaceutical vials to complex drug delivery systems, such as syringe systems, insulin pens and inhalers, for safe dosage and application. Together with our partners we develop solutions which set standards and have role-model status throughout their respective business sectors.

Our Group of companies achieves in Europe, North and South America and Asia sales of about EUR1 billion and employs around 9,400 people. Through top-class technologies, convincing innovations and targeted investments we are systematically expanding our strong market position.

For further information: Press Contact: Burkhard Lingenberg, Director Corporate Communication & Marketing, Phone [phone], Fax [phone], E-mail [email protected]; Investor Relations Contact: Anke Linnartz, Director Investor Relations, Phone [phone], Fax [phone], E-mail [email protected]